Infectious Diseases

240 An oral macrolide drug targeting the bacterial endosymbiont, Wolbachia, shows efficacy against filarial nematodes in preclinical animal models.

239 A retrievable device, compatible with nasogastric tube administration, releases grams of drug over weeks while residing in the stomach.

238 Omadacycline for Community-Acquired Bacterial Pneumonia.

237 Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers.

236 HIV peptidome-wide association study reveals patient-specific epitope repertoires associated with HIV control.

235 Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.

234 A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.

233 Epidemiology of the silent polio outbreak in Rahat, Israel, based on modeling of environmental surveillance data.

232 Seasonal flu epidemics are more diffuse in larger cities and more intense in smaller cities, where climate has a stronger influence on transmission.

231 The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study.

230 Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections.

229 Semisynthetic sensor proteins enable metabolic assays at the point of care.

228 Optimized arylomycins are a new class of Gram-negative antibiotics.

227 Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey.

226 The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.

225 Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis.

224 Bacterial Factors That Predict Relapse after Tuberculosis Therapy.

223 Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.

222 MinION genomic and case data on a recent yellow fever epidemic indicate that most infections occurred during visits to forest regions.

221 Treating elderly subjects with two low-dose mTOR inhibitors that selectively block TORC1 led to a decrease in infection rates.

Free Images for Presentation: sunipix SUNIPIX